AGL 38.20 Increased By ▲ 0.21 (0.55%)
AIRLINK 211.50 Decreased By ▼ -4.03 (-1.87%)
BOP 9.48 Decreased By ▼ -0.32 (-3.27%)
CNERGY 6.52 Decreased By ▼ -0.27 (-3.98%)
DCL 9.00 Decreased By ▼ -0.17 (-1.85%)
DFML 38.23 Decreased By ▼ -0.73 (-1.87%)
DGKC 96.86 Decreased By ▼ -3.39 (-3.38%)
FCCL 36.55 Decreased By ▼ -0.15 (-0.41%)
FFBL 88.94 No Change ▼ 0.00 (0%)
FFL 14.98 Increased By ▲ 0.49 (3.38%)
HUBC 131.00 Decreased By ▼ -3.13 (-2.33%)
HUMNL 13.44 Decreased By ▼ -0.19 (-1.39%)
KEL 5.51 Decreased By ▼ -0.18 (-3.16%)
KOSM 6.87 Decreased By ▼ -0.45 (-6.15%)
MLCF 44.90 Decreased By ▼ -0.97 (-2.11%)
NBP 59.34 Decreased By ▼ -1.94 (-3.17%)
OGDC 230.00 Decreased By ▼ -2.59 (-1.11%)
PAEL 39.20 Decreased By ▼ -1.53 (-3.76%)
PIBTL 8.38 Decreased By ▼ -0.20 (-2.33%)
PPL 200.00 Decreased By ▼ -3.34 (-1.64%)
PRL 39.10 Decreased By ▼ -1.71 (-4.19%)
PTC 27.00 Decreased By ▼ -1.31 (-4.63%)
SEARL 103.32 Decreased By ▼ -5.19 (-4.78%)
TELE 8.40 Decreased By ▼ -0.34 (-3.89%)
TOMCL 35.35 Decreased By ▼ -0.48 (-1.34%)
TPLP 13.46 Decreased By ▼ -0.38 (-2.75%)
TREET 25.30 Increased By ▲ 0.92 (3.77%)
TRG 64.50 Increased By ▲ 3.35 (5.48%)
UNITY 34.90 Increased By ▲ 0.06 (0.17%)
WTL 1.77 Increased By ▲ 0.05 (2.91%)
BR100 12,110 Decreased By -137 (-1.12%)
BR30 37,723 Decreased By -662.1 (-1.72%)
KSE100 112,415 Decreased By -1509.6 (-1.33%)
KSE30 35,508 Decreased By -535.7 (-1.49%)

The World Health Organization said on Wednesday it has set up a hub in South Korea to train low- and middle-income countries to produce their own vaccines and therapies, and is expanding its COVID-19 vaccine project to a further five nations.

The new training hub comes after the UN agency set up a technology transfer hub in Cape Town, South Africa, last year to give companies from poor and middle-income countries the know-how to produce COVID-19 vaccines based on mRNA technology.

The new hub outside Seoul will provide workforce training to all countries wishing to produce products such as vaccines, insulin, monoclonal antibodies, WHO Director General Tedros Adhanom Ghebreyesus told a press briefing.

"Currently, bio-manufacturing training facilities are located mainly in high income countries..., putting them out of reach for many lower income countries," he said.

Moderna to develop mRNA-based shingles vaccine

The facility in South Korea is already carrying out training for companies based in the country and will now accommodate trainees from other countries, the WHO said.

The WHO also said five more countries - Bangladesh, Indonesia, Pakistan, Serbia and Vietnam - will receive support from its mRNA technology transfer hub in South Africa.

The countries have been vetted by a group of experts and proved to have the capacity to move to production stage relatively quickly, the WHO said.

Last week, six African countries - Egypt, Kenya, Nigeria, Senegal, South Africa and Tunisia - signed up as the first on the continent to receive the technology to manufacture mRNA vaccines at scale and according to international standards.

China allows COVID boosters of different technologies than primary shots

On Wednesday, Tedros said that so far 20 countries had expressed interest in getting training on developing an mRNA vaccine by the South African hub.

The WHO said it is currently prioritising countries that do not have mRNA technology but already have some manufacturing infrastructure and capacity.

Comments

Comments are closed.